Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoki Oike

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Cancer Science|August 23, 2018
Prognostic impact of the tumor immune microenvironment in synovial sarcomaNaoki Oike, Hiroyuki Kawashima, Akira Ogose, et al.
Frontiers in Oncology|September 15, 2025
IgG4-related disease-like lesion arising within a well-differentiated liposarcoma/an atypical lipomatous tumor: two cases reportNaoki Oike, Tomoaki Torigoe, Akira Ogose, et al.
Plos One|June 14, 2024
Cadherin-11 contributes to the heterogenous and dynamic Wnt-Wnt-β-catenin pathway activation in Ewing sarcomaRyota Shirai, Tyler Biebighauser, Deandra Walker, et al.
Frontiers in Oncology|June 15, 2026
Case Report: Synovial sarcoma with diffuse myxoid stroma and complete absence of epithelial differentiation in the extremityTomohiro Miyazaki, Naoki Oike, Takashi Ariizumi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 29, 2025
A novel method for generating chimeric antigen receptor-transduced primary human natural killer cells by the use of multiple cytokines and anti-CD2 and anti-NKp46 stimulatory antibodiesNobuhiro Kubo, Minori Baba, Chansu Shin, et al.
Cancer Immunology, Immunotherapy : CII|April 24, 2021
Human leukocyte antigen I is significantly downregulated in patients with myxoid liposarcomasNaoki Oike, Hiroyuki Kawashima, Akira Ogose, et al.
The Tohoku Journal of Experimental Medicine|June 14, 2019
Expression Profiling of Receptor-Activator of Nuclear Factor-Kappa B Ligand in Soft Tissue TumorsTetsuro Yamagishi, Hiroyuki Kawashima, Akira Ogose, et al.
Translational Oncology|September 23, 2021
Effectiveness of 4-1BB-costimulated HER2-targeted chimeric antigen receptor T cell therapy for synovial sarcomaYudai Murayama, Hiroyuki Kawashima, Nobuhiro Kubo, et al.
The Journal of Dermatology|October 7, 2023
Deep dermatophytosis caused by Trichophyton rubrum in an elderly patient with CARD9 deficiency: A case report and literature reviewOsamu Ansai, Ryota Hayashi, Anna Nakamura, et al.
Translational Oncology|August 23, 2022
NKp44-based chimeric antigen receptor effectively redirects primary T cells against synovial sarcomaYudai Murayama, Yasushi Kasahara, Nobuhiro Kubo, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Cancer Science|August 23, 2018
Prognostic impact of the tumor immune microenvironment in synovial sarcomaNaoki Oike, Hiroyuki Kawashima, Akira Ogose, et al.
Frontiers in Oncology|September 15, 2025
IgG4-related disease-like lesion arising within a well-differentiated liposarcoma/an atypical lipomatous tumor: two cases reportNaoki Oike, Tomoaki Torigoe, Akira Ogose, et al.
Plos One|June 14, 2024
Cadherin-11 contributes to the heterogenous and dynamic Wnt-Wnt-β-catenin pathway activation in Ewing sarcomaRyota Shirai, Tyler Biebighauser, Deandra Walker, et al.
Frontiers in Oncology|June 15, 2026
Case Report: Synovial sarcoma with diffuse myxoid stroma and complete absence of epithelial differentiation in the extremityTomohiro Miyazaki, Naoki Oike, Takashi Ariizumi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 29, 2025
A novel method for generating chimeric antigen receptor-transduced primary human natural killer cells by the use of multiple cytokines and anti-CD2 and anti-NKp46 stimulatory antibodiesNobuhiro Kubo, Minori Baba, Chansu Shin, et al.
Cancer Immunology, Immunotherapy : CII|April 24, 2021
Human leukocyte antigen I is significantly downregulated in patients with myxoid liposarcomasNaoki Oike, Hiroyuki Kawashima, Akira Ogose, et al.
The Tohoku Journal of Experimental Medicine|June 14, 2019
Expression Profiling of Receptor-Activator of Nuclear Factor-Kappa B Ligand in Soft Tissue TumorsTetsuro Yamagishi, Hiroyuki Kawashima, Akira Ogose, et al.
Translational Oncology|September 23, 2021
Effectiveness of 4-1BB-costimulated HER2-targeted chimeric antigen receptor T cell therapy for synovial sarcomaYudai Murayama, Hiroyuki Kawashima, Nobuhiro Kubo, et al.
The Journal of Dermatology|October 7, 2023
Deep dermatophytosis caused by Trichophyton rubrum in an elderly patient with CARD9 deficiency: A case report and literature reviewOsamu Ansai, Ryota Hayashi, Anna Nakamura, et al.
Translational Oncology|August 23, 2022
NKp44-based chimeric antigen receptor effectively redirects primary T cells against synovial sarcomaYudai Murayama, Yasushi Kasahara, Nobuhiro Kubo, et al.
Pageof 4